Enveloped viruses utilize glycoproteins on their surface to mediate
entry into the target host cell. Conserved features in many viral
glycoproteins suggest that they function in a similar manner to
accomplish the common goal of viral entry into the host. Entry involves
both recognition of specific receptors on the host surface and fusion
of the viral and host cell membranes. The viral glycoproteins mediate
both of these events. For many viruses, viral entry takes place after
endocytosis where the acidic environment of the endosome triggers
conformational changes in the viral glycoprotein(s) that result in
membrane fusion. Fusion appears to require the concerted action of
several oligomeric glycoproteins, thus the conformational changes are
likely to also be synchronous and this synchrony is easily obtained with
a trigger such as a low pH environment. Retroviruses, including Rous
sarcoma virus (RSV), and a number of other virus families enter cells
in a pH-independent manner. Thus, the cue for the proposed glycoprotein
conformational changes for these pH-independent viruses is unclear.
Indeed, the relevant conformational changes that lead to fusion are ill-
defined for viruses utilizing a neutral pH entry pathway. Although the
glycoproteins of many pH-dependent and independent viruses are similar,
the study of neutral pH entry has been slowed by our lack of knowledge
about, or ability to trigger, a fusogenic conformation for the viral
glycoproteins. The overall goal of this project is to analyze viral
entry in a model retroviral system. Because of the availability of a
cloned host receptor (Tva) that is easily manipulated and a well
characterized viral envelope protein, RSV represents an ideal system to
study pH-independent retroviral entry. This analysis will focus on the
molecular details of the interaction of the viral envelope protein and
the receptor, the effects of this interaction on the Env protein, the
regions in Env that mediate these effects, and finally the relationship
of changes that occur in Env to membrane fusion. The specific aims to
be pursued are: 1) Produce mutations in defined regions of env and study
their effects separately on a) receptor binding, b) receptor-induced
conformational changes of envelope, c) membrane fusion, and d)
infection. 2) Employ a genetic selection strategy to isolate viruses
with alterations in envelope that allow escape from soluble receptor or
that suppress of an envelope or receptor defect. 3) Determine the
consequences of the Tva/EnvA interaction: cooperative effects on
conformational changes, characterization of activated EnvA, and analysis
of the effects of peptides to conserved regions of TM.
No Sub Projects information available for 5R01CA076256-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA076256-02
Patents
No Patents information available for 5R01CA076256-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA076256-02
Clinical Studies
No Clinical Studies information available for 5R01CA076256-02
News and More
Related News Releases
No news release information available for 5R01CA076256-02
History
No Historical information available for 5R01CA076256-02
Similar Projects
No Similar Projects information available for 5R01CA076256-02